December 17, 2009Critical Care Medicine
Ten reasons why we should NOT use severity scores as entry criteria for clinical trials or in our treatment decisions*
Key result
Severity of illness scores, such as APACHE II, are poor surrogates for risk stratification and should not be used as criteria for clinical trial enrollment or individual treatment decisions.
Design
Editorial
Authors
Discussion
Loading...
Member takes
Implication
Severity of illness scores are poor surrogates for risk stratification and should not be used for clinical trial enrollment or individual treatment decisions.
PICO
I
Intervention / Comparator
Severity scores (e.g., APACHE II)
Severity of illness scores are poor surrogates for risk stratification and should not be used for clinical trial enrollment or individual treatment decisions.
Cite This Study
Vincent et al. (2009) reported a review. Severity scores (e.g., APACHE II) was evaluated. Severity of illness scores, such as APACHE II, are poor surrogates for risk stratification and should not be used as criteria for clinical trial enrollment or individual treatment decisions.